SBCMA predicts progression and is a biomarker of response in myeloma precursor disease followed on prospective studies Meeting Abstract


Authors: Tan, W.; Kunacheewa, C.; Becnel, M.; Lee, H.; Patel, K.; Berrios, D.; Huang, M.; Thomas, S.; Lin, P.; Berkova, Z.; Weber, D.; Kuiatse, I.; Korde, N.; Jagannath, S.; Landgren, O.; Orlowski, R.; Manasanch, E.
Abstract Title: SBCMA predicts progression and is a biomarker of response in myeloma precursor disease followed on prospective studies
Meeting Title: 20th Annual Meeting and Exposition of the International Myeloma Society
Journal Title: Clinical Lymphoma, Myeloma and Leukemia
Volume: 23
Issue: Suppl. 2
Meeting Dates: 2023 Sep 27-30
Meeting Location: Athens, Greece
ISSN: 2152-2650
Publisher: Elsevier Inc.  
Date Published: 2023-09-01
Start Page: S22
Language: English
ACCESSION: WOS:001079705400037
PROVIDER: wos
DOI: 10.1016/S2152-2650(23)01603-8
Notes: Meeting Abstract: OA-36 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Neha Sanat Korde
    226 Korde